This underscores the need for close monitoring when combining QUE-containing supplements with drugs metabolized by P-gp or CYP3A4 (e.g., cyclosporine)
One person severe reaction becomes the expected experience in the minds of readers, even though that reaction may represent a fraction of a percent of users
Chialva M, di Fossalunga AS, Daghino S, Ghignone S, Bagnaresi P, Chiapello M, et al
Solution structure of the DNA binding domain of the human forkhead transcription factor AFX (FOXO4)
This increased pressure in the portal vein may lead to the development of large, swollen veins (varices) within the esophagus, stomach, rectum, or umbilical area (belly button)
A16AA01 S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R